← Back to Screener
Tenaya Therapeutics, Inc. Common Stock (TNYA)
Price$0.74
Favorite Metrics
Price vs S&P 500 (26W)-71.50%
Price vs S&P 500 (4W)-5.35%
Market Capitalization$169.71M
All Metrics
Book Value / Share (Quarterly)$0.57
P/TBV (Annual)0.51x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.32
Price vs S&P 500 (YTD)5.71%
EPS (TTM)$-0.63
10-Day Avg Trading Volume3.12M
EPS Excl Extra (TTM)$-0.63
EPS (Annual)$-0.59
ROI (Annual)-73.50%
Cash / Share (Quarterly)$0.46
ROA (Last FY)-61.66%
EBITD / Share (TTM)$-0.56
ROE (5Y Avg)-71.82%
Cash Flow / Share (Annual)$-0.32
P/B Ratio1.38x
P/B Ratio (Quarterly)1.25x
Net Income / Employee (Annual)$-1
ROA (TTM)-69.96%
EPS Incl Extra (Annual)$-0.59
Current Ratio (Annual)6.84x
Quick Ratio (Quarterly)6.58x
3-Month Avg Trading Volume5.05M
52-Week Price Return69.29%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.42
52-Week High$2.35
EPS Excl Extra (Annual)$-0.59
CapEx CAGR (5Y)-42.42%
26-Week Price Return-62.76%
Quick Ratio (Annual)6.58x
13-Week Price Return3.32%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)6.84x
Enterprise Value$69.168
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.46
3-Month Return Std Dev123.71%
Net Income / Employee (TTM)$-1
ROE (Last FY)-73.50%
EPS Basic Excl Extra (Annual)$-0.59
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.63
ROI (TTM)-85.20%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$3.64
Price vs S&P 500 (52W)34.19%
Year-to-Date Return9.85%
5-Day Price Return9.34%
EPS Normalized (Annual)$-0.59
ROA (5Y Avg)-58.91%
Month-to-Date Return13.02%
Cash Flow / Share (TTM)$-1.73
EBITD / Share (Annual)$-0.55
ROI (5Y Avg)-71.82%
EPS Basic Excl Extra (TTM)$-0.63
P/TBV (Quarterly)0.76x
P/B Ratio (Annual)1.25x
Book Value / Share (Annual)$0.57
Price vs S&P 500 (13W)0.45%
Beta2.98x
Revenue / Share (TTM)$0.00
ROE (TTM)-85.20%
52-Week Low$0.36
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.21
4.21
4.21
4.21
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
TNYATenaya Therapeutics, Inc. Common Stock | — | — | — | — | $0.74 |
AMGNAmgen Inc | 5.20x | 9.95% | 73.30% | 2.93% | $350.16 |
GILDGilead Sciences Inc | 5.71x | 2.40% | 78.83% | 133.64% | $135.87 |
ARGXargenx SE American Depositary Shares | 12.59x | 89.56% | 150.91% | — | $834.45 |
BNTXBioNTech SE American Depositary Share | 9.06x | -11.81% | 84.21% | — | $105.19 |
BIIBBiogen Inc. Common Stock | 2.72x | 2.22% | 75.69% | -18.77% | $183.34 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $54.59 |
NBIXNeurocrine Biosciences Inc | 4.64x | 21.45% | 98.18% | 2.31% | $131.59 |
EXELExelixis Inc | 4.89x | 6.85% | 96.39% | 31.10% | $43.61 |
TECHBio-Techne Corp. | 7.72x | 1.64% | 66.60% | -20.58% | $60.58 |
IBRXImmunityBio, Inc. Common Stock | 74.42x | 668.31% | 99.34% | — | $8.20 |
About
Tenaya Therapeutics is a preclinical-stage biotech company developing curative therapies for heart disease across three platforms: gene therapy, cellular regeneration, and precision medicine. The company targets the root causes of cardiac disease, aiming to deliver transformative treatments addressing significant unmet medical needs.